Ultrasonographic Predictors of Adductor Canal Block Effectiveness in Total Knee Arthroplasty
1 other identifier
observational
623
1 country
1
Brief Summary
Total knee arthroplasty (TKA) is associated with substantial postoperative pain and opioid requirements, making effective multimodal analgesia essential for early mobilization, functional recovery, and reduction of opioid-related adverse events \[1,2\]. Adductor canal block (ACB) has become a key component of enhanced recovery after surgery (ERAS) protocols because it provides effective anterior knee analgesia while largely preserving quadriceps muscle strength \[2-4\]. However, analgesic efficacy after ACB remains variable, and some patients require rescue opioid analgesia despite technically successful block placement \[5\]. Although ultrasound guidance improves block accuracy, factors such as tissue depth, anatomical variations, saphenous nerve visibility, and injectate spread pattern may influence clinical outcomes \[6,7\]. Prospective evidence regarding the predictive value of these ultrasound-derived parameters for ACB analgesic failure remains limited. Therefore, this study aims to evaluate whether preoperative ultrasound-derived tissue and target parameters-including skin-to-target depth, subcutaneous fat thickness, muscle thickness, saphenous nerve visibility, and injectate spread pattern-can predict ACB analgesic failure and early postoperative analgesic outcomes following TKA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2026
CompletedStudy Start
First participant enrolled
July 13, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 13, 2027
July 28, 2026
July 1, 2026
1 year
July 13, 2026
July 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ACB Failure
ACB analgesic failure will be defined as the requirement for rescue analgesia during the first 24 hours after block administration, with intravenous tramadol (1 mg/kg) administered to patients with an NRS pain score ≥4.
0-24 hours
Secondary Outcomes (2)
Secondary outcome
0-24 hour
Tramadol Consumption
0-24 Hours
Interventions
The adductor canal block (ACB) will be performed in the post-anesthesia care unit (PACU) after regression of spinal anesthesia.
Eligibility Criteria
Scheduled for elective primary unilateral total knee arthroplasty under spinal anesthesia
You may qualify if:
- Age ≥18 years
- Scheduled for elective primary unilateral total knee arthroplasty under spinal anesthesia
- American Society of Anesthesiologists (ASA) physical status I-III
You may not qualify if:
- Daily opioid use or chronic pain syndrome
- Diabetic or other clinically diagnosed peripheral neuropathy
- Coagulopathy
- Infection at the injection site
- Known allergy or hypersensitivity to local anesthetics
- Revision total knee arthroplasty
- Conversion from spinal anesthesia to general anesthesia during surgery
- General anesthesia as the planned anesthetic technique
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Konya City Hospital
Konya, Konya, 42090, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 13, 2026
First Posted
July 28, 2026
Study Start
July 13, 2026
Primary Completion (Estimated)
July 13, 2027
Study Completion (Estimated)
July 13, 2027
Last Updated
July 28, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share